BNO 0.00% 1.0¢ bionomics limited

"However the trial is likely to see these companies consider...

  1. 1,268 Posts.
    "However the trial is likely to see these companies consider BNC105 as an option in sub groups rather than as a broad based application which is likely to lower the value of the partnering deal BNO achieves"

    Is putting this in an announcement necessary from ASX reporting rules. As soon as I read that, straight from CEO's mouth, I gulped. Too late. Whilst it may be true, not good for CEO to be espousing it.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.